Norway health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
February 2026 — Vol. 3, No. 2
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, February 2026KP declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Zhuhai export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
India caps exenatide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
TRIUMPH-3 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
India pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Independent analysis puts a JEEP mazdutide lot at 98.9%, against 97.7% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
HJ declines, for the 24th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A shortage listing ends. 23 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The 9-day notice: how a compounding wind-down works in Ireland
The document is four pages. Three of them are about dates.
What a 9% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
Medutest result on a Shenzhen retatrutide lot lands 2.4 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
Poland pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
TFC declines, for the 5th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Ireland declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
From the floor in Shenzhen: 18 posters, one theme
Reported from the sessions, and from the two hours afterwards.